Effect of glycopyrrolate and brompheniramine maleate on the recurrence rate of duodenal ulcer.
D001966:Bromine / Q000627:therapeutic use*; D001977:Brompheniramine / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000517:prevention & control*; D006024:Glycopyrrolate / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D008333:Mandelic Acids; D010276:Parasympatholytics; D011725:Pyridines; D011759:Pyrrolidines; D000644:Quaternary Ammonium Compounds; D001977:Brompheniramine; D001966:Bromine; D006024:Glycopyrrolate